Form 4 holding
CFO & Executive Vice President
Ultragenyx Pharmaceutical Inc.
- Security class
- Common Stock
- Shares / value
- 66,695
- Estimated value
- $1,400,595
- Report date
- 14 Oct 2022
- Price
- $21.00
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|